title: The significance of MGMT protein detection in evaluation of osteosarcoma necrosis rate after cisplatin chemotherapy.
abstract: The aim of this article was to investigate the correlation between expression of O(6)-methylguanine-DNA methyltransferase (MGMT) in osteosarcoma and the curative effect of alkylating agent (Cis-diaminodichloroplatinum, CDDP). 42 male patients and 34 female patients with a median age of 17 years (9 to 43 years) were eligible for this study. According to histopathological types, there were 3 cases of telangiectatic osteogenic sarcoma, 22 cases of osteoblastic, 11 cases of chondroblastic and 16 cases of fibroblastic sarcoma. Immunohistochemical method was used to detect the expression of MGMT protein. The correlations between MGMT expression and the curative effect of CDDP on osteosarcoma have been investigated. It was shown by immunohistochemical staining that among 76 osteosarcoma biopsy specimens, 52 (68%) cases were positive, 27 (35%) cases were weak positive, 18 (24%), cases were moderate positive, and 7 (9%) cases were strong positive. There were no significant differences in MGMT expression among different pathological types of tumors (p>0.5). After CDDP chemotherapy, among pathologic specimens in which MGMT expression was positive, necrosis rates were as follows: grade I, 5 cases (38%); grade II, 7 cases (25%); grade III, 15 cases (21%); grade IV, 2 cases (23%). Osteosarcoma necrosis rate was low when the expression of MGMT protein was positive, whereas necrosis rate was high when there was a low level of MGMT expression (p<0.01). There was a significant negative correlation between the level of MGMT expression in osteosarcoma tissue and osteosarcoma necrosis rate after cisplatin chemotherapy.
authors: Department of Orthopedics, the Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China.
authors: Qiu
authors: Q
authors: Cui
authors: Dingfeng
authors: D
authors: Li
authors: Cheng
authors: C
authors: Liu
authors: Jun
authors: J
authors: Guo
authors: Shubin
authors: S
authors: Liu
authors: Yaosheng
authors: Y
authors: Liu
authors: Xiaohong
authors: X
authors: Wang
authors: Yanjun
authors: Y
authors: Zeng
references: Curr Opin Pharmacol. 2006 Aug;6(4):355-63
references: 16777483
references: Br Med Bull. 2008;85:17-33
references: 18245773
references: Int J Cancer. 1995 May 4;61(3):321-6
references: 7729942
references: Int J Cancer. 2008 Sep 1;123(5):1215-8
references: 18546261
references: Recent Pat Anticancer Drug Discov. 2006 Jan;1(1):129-34
references: 18221032
references: DNA Repair (Amst). 2007 Aug 1;6(8):1155-60
references: 17482895
references: Nat Rev Cancer. 2008 Mar;8(3):193-204
references: 18256616
references: Int J Cancer. 1998 Sep 11;77(6):919-22
references: 9714064
references: Cancer. 1982 Mar 15;49(6):1221-30
references: 6174200
references: Pathol Oncol Res. 2004;10(3):133-41
references: 15448748